175 results
Keyword sertralin Remove keyword
-
List item
Referral: Zoloft
sertraline, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 27/03/2009, Last updated: 07/05/2009contains the active substance sertraline. Sertraline is a selective serotonin … Serlain, Lustral, Tatig, Sertraline and Besitran. Why was Zoloft … containing 25 mg, 50 mg or 100 mg sertraline Concentrate for oral solution … -
List item
Referral: Serotonin-specific reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors
atomoxetine, citalopram, escitalopram, fluoxetine, fluvoxamine, mianserine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/04/2005, EC decision date: 19/08/2005, Last updated: 03/11/2005mirtazapine, paroxetine, reboxetine, sertraline and venlafaxine. The review … mirtazapine, paroxetine, reboxetine, sertraline and venlafaxine; clinical … mirtazapine, paroxetine, reboxetine, sertraline and venlafaxine containing … -
List item
Human medicine European public assessment report (EPAR): Valdoxan
Agomelatine, Depressive Disorder, Major
Date of authorisation: 19/02/2009, Revision: 24, Authorised, Last updated: 08/08/2022study comparing Valdoxan with sertraline (another antidepressant … Valdoxan was more effective than sertraline, with a reduction in HAM D … study comparing Valdoxan with sertraline (another antidepressant … -
List item
Human medicine European public assessment report (EPAR): Thymanax
Agomelatine, Depressive Disorder, Major
Date of authorisation: 19/02/2009,
Date of refusal: 18/11/2006, Revision: 24, Withdrawn, Last updated: 08/08/2022study comparing Thymanax with sertraline (another antidepressant … Thymanax was more effective than sertraline, with a reduction in HAM D … study comparing Thymanax with sertraline (another antidepressant … -
List item
National expert: Caroline Gjestad, Norwegian Medicines Agency (updated)
- Declaration of interests - 39.35 KB | PDF
- Curriculum Vitae - 27.06 KB | PDF
Citalopram, Escitalopram, and Sertraline; Therapeutic Drug Monitoring … -
List item
News: European Medicines Agency finalises review of antidepressants in children and adolescents
CHMP, Last updated: 25/04/2005mirtazapine, paroxetine, reboxetine, sertraline and venlafaxine. The review … paroxetine, reboxetine, sertraline and venlafaxine. 2. A previous … paroxetine, reboxetine, sertraline and venlafaxine; clinical … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,15-18 December 2008
CHMP, Last updated: 18/12/2008and associated names (sertraline), from Pfizer group of companies … -
List item
Human medicine European public assessment report (EPAR): Diacomit
stiripentol, Myoclonic Epilepsy, Juvenile
Date of authorisation: 03/01/2007,
Date of refusal: 11/02/2009, Revision: 18, Authorised, Last updated: 25/08/2023 -
List item
Human medicine European public assessment report (EPAR): Akynzeo (updated)
netupitant, palonosetron hydrochloride, Vomiting; Neoplasms; Nausea; Cancer
Date of authorisation: 27/05/2015, Revision: 16, Authorised, Last updated: 08/09/2023 -
List item
Human medicine European public assessment report (EPAR): Lumeblue (previously known as Methylthioninium chloride Cosmo) (updated)
methylthioninium chloride, Colorectal Neoplasms; Colonoscopy
Date of authorisation: 19/08/2020, Revision: 3, Authorised, Last updated: 18/09/2023 -
List item
Human medicine European public assessment report (EPAR): Melatonin Neurim (updated)
melatonin, Sleep Initiation and Maintenance Disorders
Date of authorisation: 07/11/2022, Revision: 1, Authorised, Last updated: 15/09/2023 -
List item
Human medicine European public assessment report (EPAR): Spravato
esketamine hydrochloride, Depressive Disorder
Date of authorisation: 18/12/2019,
, Revision: 8, Authorised, Last updated: 14/07/2023
-
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Krka
efavirenz, emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 08/02/2018,
, Revision: 10, Authorised, Last updated: 20/06/2023
-
List item
Human medicine European public assessment report (EPAR): Xospata
gilteritinib fumarate, Leukemia, Myeloid, Acute
Date of authorisation: 24/10/2019,, 
, Revision: 4, Authorised, Last updated: 18/07/2023
-
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva
efavirenz, emtricitabine, tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 17/07/2017,, Revision: 10, Authorised, Last updated: 01/06/2023
-
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
efavirenz, emtricitabine, tenofovir disoproxil maleate, HIV Infections
Date of authorisation: 05/09/2017,, Revision: 15, Authorised, Last updated: 30/05/2023
-
List item
Human medicine European public assessment report (EPAR): Sustiva
efavirenz, HIV Infections
Date of authorisation: 28/05/1999, Revision: 48, Authorised, Last updated: 25/05/2023 -
List item
Human medicine European public assessment report (EPAR): Darunavir Mylan
darunavir, HIV Infections
Date of authorisation: 03/01/2017,, Revision: 13, Authorised, Last updated: 23/05/2023
-
List item
Human medicine European public assessment report (EPAR): Brintellix
Vortioxetine, Depressive Disorder, Major
Date of authorisation: 18/12/2013, Revision: 22, Authorised, Last updated: 02/08/2023 -
List item
Human medicine European public assessment report (EPAR): Eurartesim (updated)
piperaquine tetraphosphate, Artenimol, Malaria
Date of authorisation: 27/10/2011, Revision: 13, Authorised, Last updated: 30/08/2023 -
List item
Human medicine European public assessment report (EPAR): Stocrin
efavirenz, HIV Infections
Date of authorisation: 28/05/1999, Revision: 49, Authorised, Last updated: 25/04/2023 -
List item
Human medicine European public assessment report (EPAR): Darunavir Krka
darunavir, HIV Infections
Date of authorisation: 26/01/2018,, Revision: 10, Authorised, Last updated: 15/05/2023
-
List item
Human medicine European public assessment report (EPAR): Buvidal
buprenorphine, Opioid-Related Disorders
Date of authorisation: 20/11/2018, Revision: 8, Authorised, Last updated: 16/08/2023 -
List item
Human medicine European public assessment report (EPAR): Orkambi
Lumacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 19/11/2015, Revision: 32, Authorised, Last updated: 27/07/2023 -
List item
Human medicine European public assessment report (EPAR): Azilect
rasagiline, Parkinson Disease
Date of authorisation: 21/02/2005, Revision: 23, Authorised, Last updated: 18/08/2023